Korean J Anesthesiol Search

CLOSE


Korean J Anesthesiol > Epub ahead of print
Running title
Authors Initials YJ Bang, JS Ko, R Kang
DOI: https://doi.org/10.4097/kja.26205    [Epub ahead of print]
Published online July 29, 2026.
Comparative analgesic effects of lidocaine–dexmedetomidine co-administration in major laparoscopic gynecologic surgery: a randomized controlled trial
Yu Jeong Bang1, Justin Sangwook Ko2, RyungA Kang1,4, Tae Soo Hahm1, Chug Su Kim1, So Myung Kong1, Yoo-Young Lee3, Chel Hun Choi3, Minsuk Chae4,5
1Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
2Department of Anesthesiology, Froedtert Hospital, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
4Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, North Carolina, United States
5Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Corresponding author:  RyungA Kang, Tel: +81-2-3410-0369, 
Email: ryunga.kang@samsung.com
Received: 25 February 2026   • Revised: 28 July 2026   • Accepted: 28 July 2026
*Yu Jeong Bang and Justin Sangwook Ko contributed equally to this study as co-first authors.
Abstract
Background
The intraoperative co-administration of lidocaine and dexmedetomidine has been proposed as an opioid-sparing strategy; however, its effectiveness as an intraoperative multimodal analgesia (MMA) strategy remains unclear. We evaluated its effect on postoperative opioid consumption in patients undergoing major laparoscopic gynecologic surgery.
Methods
We conducted a randomized controlled trial comparing intraoperative placebo with lidocaine–dexmedetomidine co-administration in patients undergoing major laparoscopic gynecologic surgery within a standardized Enhanced Recovery after Surgery (ERAS) pathway. Patients were assigned to receive intraoperative placebo or lidocaine at 1.5 mg/kg/h co-administered with dexmedetomidine at either 0.4 or 0.7 μg/kg/h. The primary outcome was 24-h cumulative opioid consumption.
Results
Twenty-four-hour cumulative opioid consumption differed significantly between the groups (P = 0.004). Median morphine-equivalent dose was 16.6 mg (12.1, 22.3) in the control group, 11.3 mg (8.1, 19.5) in the lidocaine–dexmedetomidine 0.4 group, and 11.1 mg (6.8, 16.5) in the 0.7 group, corresponding to relative reductions of 32% and 33% in median consumption, respectively. Both dexmedetomidine doses (0.4 and 0.7 μg/kg/h), when co-administered with lidocaine, were associated with significantly lower opioid consumption than the control group, with no significant differences between the two doses. Pain scores during mobilization were lower in both treatment groups during the first 48 h postoperatively, without an increase in adverse events.
Conclusion
Intraoperative co-administration of lidocaine and dexmedetomidine effectively reduced postoperative opioid consumption and pain during mobilization as an intraoperative MMA strategy within an ERAS pathway. The higher dexmedetomidine dose provided no additional opioid-sparing benefit during the first 24 postoperative hours.
Key Words: Lidocaine; Dexmedetomidine; Combined anesthetics; Post-operative pain; Gynecologic surgery; Enhanced recovery after surgery
TOOLS
Share :
Facebook Twitter Linked In Line it
METRICS Graph View
  • 0 Crossref
  •    
  • 992 View
  • 67 Download


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                
Business Name: Korean Society of Anesthesiologists
Business Registration: 106-82-07194
Representative: Young-Tae Jeon

Copyright © 2026 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next